ZuriMED Closes Series-A Financing Round

ZuriMED Closes Series-A Financing Round

Empowered by the successful closure of our Series-A Financing Round counting 14.5 million CHF, we are boosting our path to market entry for the Surgical-Fiberlock™ technology! For more information, please read our press...
ZuriMED @ AAOS 2023

ZuriMED @ AAOS 2023

ZuriMED will participate at the American Academy of Orthopaedic Surgeons (AAOS) 2023 in Las Vegas! Visit us at our booth No. 4155. We would be thrilled to introduce our latest technology to...
ZuriMED @ BIO 2022

ZuriMED @ BIO 2022

Are you also participating in the BIO 2022 in San Diego from the 13th to the 16th June? We would be thrilled to meet you at booth 2427! Feel free to contact us for further...
Innosuisse Project Grant Application

Innosuisse Project Grant Application

ZuriMED is delighted to announce that our Innosuisse Project grant application has been approved, supporting the co-development with our research partner University Hospital Balgrist on our breakthrough technology for soft tissue repair. We thank Innosuisse very much...
Innosuisse Scale-Up Award

Innosuisse Scale-Up Award

Important step toward expansion for ZuriMED Technologies AG We are thrilled to announce, that we received the Innosuisse Scale-up Award! After an intensive phase, where we presented our objectives and concept for commercial growth to a committee of experts and...